Literature DB >> 11193748

Membranous glomerulonephritis associated with diffuse malignant pleural mesothelioma: report of a case.

K Sakamoto1, H Suzuki, T Jojima.   

Abstract

Membranous glomerulonephritis is associated with a variety of malignant neoplasms. However, an association between membranous glomerulonephritis and pleural mesothelioma is very rare. We report herein a case of pleural mesothelioma associated with membranous glomerulonephritis. A 52-year-old man with severe proteinuria was diagnosed to have diffuse malignant pleural mesothelioma. A left extrapleural pneumonectomy was thus performed. The proteinuria resolved postoperatively. However, 6 months postoperatively, the proteinuria recurred. A renal biopsy revealed membranous glomerulonephritis. Simultaneously, a recurrence of the mesothelioma in the left pleural cavity was confirmed. Although rare, membranous glomerulonephritis appears to be one type of paraneoplastic syndrome associated with malignant pleural mesothelioma.

Entities:  

Mesh:

Year:  2000        PMID: 11193748     DOI: 10.1007/s005950070014

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  4 in total

Review 1.  Minimal change disease associated with malignant pleural mesothelioma: case report and review of the literature.

Authors:  Halil Yildiz; Stoian Ioana Andreea; Delphine Hoton; Jean Cyr Yombi
Journal:  BMJ Case Rep       Date:  2016-12-19

2.  Mesothelioma of the testis and nephrotic syndrome: a case report.

Authors:  Justine Bacchetta; Dominique Ranchère; Frédérique Dijoud; Jean-Pierre Droz
Journal:  J Med Case Rep       Date:  2009-06-05

3.  Concomitant Nephrotic Syndrome and Cryoglobulinemia in a Case of Malignant Mesothelioma.

Authors:  Kei Nagai; Hiroaki Tachi; Kohei Inoue; Atsushi Ueda
Journal:  Case Rep Nephrol       Date:  2022-09-28

4.  Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximab.

Authors:  Jamie S Lin; Daniel Y Wang; Omar Mamlouk; William F Glass; Maen Abdelrahim; Cassian Yee; Ala Abudayyeh
Journal:  J Immunother Cancer       Date:  2020-10       Impact factor: 13.751

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.